miércoles, 1 de mayo de 2019

FDA Approves Kalydeco for the Treatment of 6-12 months-old Toddlers with CF - Cystic Fibrosis News Today

FDA Approves Kalydeco for the Treatment of 6-12 months-old Toddlers with CF - Cystic Fibrosis News Today

Cystic Fibrosis News Today



FDA Approves Kalydeco for the Treatment of 6-12 months-old Toddlers with CF


No hay comentarios:

Publicar un comentario